From: The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis
Potential savings (per inhabitant)
Canada
$146.4 million ($4.68)
France
$95.3 million ($1.61)
Germany
$214.1 million ($2.59)
Norway
$24.1 million ($5.38)
UK
$199.8 million ($3.36)
US
$1 340.6 million ($4.86)